Cas9 degradation in human cells using phage anti-CRISPR proteins

• Zuriah Meacham ,

  Contributed equally to this work with: Zuriah Meacham, Luisa Arake de Tacca

  Roles Investigation, Writing – review & editing

  Affiliation Acrigen Biosciences, Inc., Alameda, California, United States of America

  ⨯
• Luisa Arake de Tacca ,

  Contributed equally to this work with: Zuriah Meacham, Luisa Arake de Tacca

  Roles Conceptualization, Investigation, Writing – original draft

  Affiliation Acrigen Biosciences, Inc., Alameda, California, United States of America

  ⨯
• Joseph Bondy-Denomy,

  Roles Writing – review & editing

  Affiliation Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• David Rabuka,

  Roles Conceptualization, Funding acquisition, Writing – review & editing

  Affiliation Acrigen Biosciences, Inc., Alameda, California, United States of America

  ⨯
• Michael Schelle

  Roles Conceptualization, Investigation, Writing – review & editing

  * E-mail: michael.schelle@acrigen.com

  Affiliation Acrigen Biosciences, Inc., Alameda, California, United States of America

  https://orcid.org/0000-0002-9494-5464

  ⨯